Fate Therapeutics Inc (NASDAQ:FATE)

6.46
Delayed Data
As of Feb 08
 -0.38 / -5.56%
Today’s Change
4.02
Today|||52-Week Range
43.12
-35.98%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Tahl Cindy R
Secretary & General Counsel
Sale4/01/202225,000$38.85$971.3K-84.37%
Wolchko J Scott
President & Chief Executive Officer
Sale4/21/202222,715$34.57$785.3K-81.29%
Mendlein John D
Director
Sale3/10/202219,493$34.73$677.0K-81.79%
Wolchko J Scott
President & Chief Executive Officer
Sale7/21/202219,171$33.07$634.0K-80.62%
Valamehr Bahram
Chief Research & Development Officer
Sale7/07/202217,158$30.23$518.7K-79.11%
Valamehr Bahram
Chief Research & Development Officer
Sale3/14/202216,678$30.36$506.3K-78.23%
Mendlein John D
Director
Buy1/11/202388,048$5.67$499.2K+12.94%
Mendlein John D
Director
Sale3/10/202212,069$35.48$428.2K-81.79%
Wolchko J Scott
President & Chief Executive Officer
Sale7/21/202210,829$32.54$352.4K-80.62%
Wolchko J Scott
President & Chief Executive Officer
Sale4/22/20229,162$34.54$316.5K-81.35%
Page of 7